We are live on ! Find out more
VYNE icon

VYNE Therapeutics
VYNE

106 hedge funds and large institutions have $160M invested in VYNE Therapeutics in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 11 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

427% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 11

73% more capital invested

Capital invested by funds: $92.7M → $160M (+$67.5M)

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

14% more funds holding

Funds holding: 93 → 106 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 0.79% → 0.7% (-0.09%)

Holders
106
Holders Change
+13
Holders Change %
+13.98%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
35
Increased
58
Reduced
11
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$30.5M
2
Franklin Resources
Franklin Resources
California
+$12.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M
4
BlackRock
BlackRock
New York
+$9.87M
5
6CM
683 Capital Management
New York
+$6.68M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$4.43M
2
VP
venBio Partners
California
-$3.92M
3
MP
Mangrove Partners
Connecticut
-$2.83M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.68M
5
O
OrbiMed
New York
-$2.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$667K -$49K -362 -6%
SSA
27
Schonfeld Strategic Advisors
New York
$657K +$713K +5,268 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$614K +$338K +2,499 +103%
Renaissance Technologies
29
Renaissance Technologies
New York
$535K +$582K +4,295 New
Ameriprise
30
Ameriprise
Minnesota
$520K +$361K +2,663 +188%
Charles Schwab
31
Charles Schwab
California
$495K +$354K +2,611 +192%
PVH
32
Psagot Value Holdings
Israel
$467K +$383K +2,827 +306%
SFI
33
Susquehanna Fundamental Investments
Pennsylvania
$446K +$485K +3,578 New
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$411K +$354K +2,617 +382%
AllianceBernstein
35
AllianceBernstein
Tennessee
$367K +$399K +2,946 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$333K +$325K +2,399 +879%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$278K +$170K +1,256 +129%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$258K +$242K +1,789 +632%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$248K +$180K +1,329 +200%
Barclays
40
Barclays
United Kingdom
$219K +$196K +1,446 +479%
CL
41
CSS LLC
Illinois
$218K +$153K +1,127 +181%
Wells Fargo
42
Wells Fargo
California
$200K +$117K +861 +116%
Commonwealth Equity Services
43
Commonwealth Equity Services
Massachusetts
$179K +$8.94K +66 +5%
UBS Group
44
UBS Group
Switzerland
$178K +$117K +861 +152%
Goldman Sachs
45
Goldman Sachs
New York
$177K +$86.7K +640 +82%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$169K +$177K +1,304 +2,661%
BPA
47
Beacon Pointe Advisors
California
$166K +$181K +1,338 New
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$164K -$134K -991 -43%
MA
49
MYDA Advisors
New York
$161K +$176K +1,296 New
HighTower Advisors
50
HighTower Advisors
Illinois
$152K +$167K +1,236 New
1
2
3 4 5

VYNE Hedge Fund Activity: Q2 2020 in Review

106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in VYNE Therapeutics (VYNE) for Q2 2020, worth a combined $160M — up 73% from $92.7M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new VYNE positions and 22 closed out — a net gain of 13 holders — while 58 added to existing stakes and 11 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $30.5M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.43M sold.

  • 106 institutional investors held VYNE Therapeutics (VYNE) as of Q2 2020, up from 93 in Q1 2020.
  • Funds reported $160M of VYNE Therapeutics stock for Q2 2020, up 73% quarter-over-quarter.
  • 35 funds opened new VYNE Therapeutics positions in Q2 2020 and 22 closed out, a net change of +13 holders.
  • The largest VYNE Therapeutics buyer in Q2 2020 was Perceptive Advisors, an estimated $30.5M added.
  • The largest VYNE Therapeutics seller in Q2 2020 was Great Point Partners, an estimated $4.43M sold.

Based on aggregated 13F filings for Q2 2020.